S Bank Fund Management Ltd Sells 193 Shares of Agilent Technologies, Inc. $A

by · The Cerbat Gem

S Bank Fund Management Ltd cut its stake in shares of Agilent Technologies, Inc. (NYSE:AFree Report) by 6.5% in the 2nd quarter, Holdings Channel.com reports. The fund owned 2,756 shares of the medical research company’s stock after selling 193 shares during the period. S Bank Fund Management Ltd’s holdings in Agilent Technologies were worth $325,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of A. Stone House Investment Management LLC bought a new position in shares of Agilent Technologies during the first quarter valued at $30,000. Ransom Advisory Ltd bought a new position in shares of Agilent Technologies during the first quarter valued at $32,000. Central Pacific Bank Trust Division bought a new position in shares of Agilent Technologies during the second quarter valued at $33,000. Zions Bancorporation National Association UT bought a new position in shares of Agilent Technologies during the first quarter valued at $38,000. Finally, Costello Asset Management INC bought a new position in shares of Agilent Technologies during the first quarter valued at $47,000.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on A shares. Rothschild Redb upgraded Agilent Technologies to a “strong-buy” rating in a report on Wednesday, October 8th. Evercore ISI lifted their price objective on Agilent Technologies from $128.00 to $140.00 and gave the stock an “in-line” rating in a report on Tuesday, October 7th. Barclays lifted their price objective on Agilent Technologies from $125.00 to $150.00 and gave the stock an “equal weight” rating in a report on Thursday, October 2nd. Robert W. Baird lifted their price objective on Agilent Technologies from $141.00 to $142.00 and gave the stock an “outperform” rating in a report on Thursday, August 28th. Finally, Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a report on Friday, October 3rd. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $149.62.

Get Our Latest Report on Agilent Technologies

Agilent Technologies Trading Up 1.1%

Shares of NYSE:A opened at $141.14 on Friday. The stock has a market capitalization of $40.01 billion, a price-to-earnings ratio of 33.13, a PEG ratio of 4.56 and a beta of 1.26. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25. The stock’s 50-day simple moving average is $127.03 and its two-hundred day simple moving average is $117.63. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $153.84.

Agilent Technologies (NYSE:AGet Free Report) last announced its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.37. The business had revenue of $1.74 billion for the quarter, compared to analysts’ expectations of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The business’s revenue for the quarter was up 10.1% on a year-over-year basis. During the same period last year, the firm posted $1.32 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 22nd. Shareholders of record on Tuesday, September 30th will be given a $0.248 dividend. This represents a $0.99 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 30th. Agilent Technologies’s dividend payout ratio (DPR) is presently 23.24%.

Agilent Technologies Profile

(Free Report)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

See Also

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:AFree Report).